AngioDynamics, Inc. (ANGO)
15.87
-0.26
(-1.61%)
USD |
NASDAQ |
Sep 01, 16:00
15.87
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Net Income (TTM) : -36.74M for May 31, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| May 31, 2026 | -36.74M |
| February 28, 2026 | -31.39M |
| November 30, 2025 | -27.71M |
| August 31, 2025 | -32.10M |
| May 31, 2025 | -33.99M |
| February 28, 2025 | -41.39M |
| November 30, 2024 | -224.72M |
| August 31, 2024 | -243.03M |
| May 31, 2024 | -184.35M |
| February 29, 2024 | -192.37M |
| November 30, 2023 | -14.12M |
| August 31, 2023 | 6.446M |
| May 31, 2023 | -52.44M |
| February 28, 2023 | -37.24M |
| November 30, 2022 | -32.71M |
| August 31, 2022 | -32.58M |
| May 31, 2022 | -26.55M |
| February 28, 2022 | -39.75M |
| November 30, 2021 | -38.34M |
| August 31, 2021 | -34.25M |
| May 31, 2021 | -31.55M |
| February 28, 2021 | -168.15M |
| November 30, 2020 | -170.31M |
| August 31, 2020 | -168.78M |
| May 31, 2020 | -165.79M |
| Date | Value |
|---|---|
| February 29, 2020 | -6.967M |
| November 30, 2019 | -5.867M |
| August 31, 2019 | -6.718M |
| May 31, 2019 | -11.15M |
| February 28, 2019 | -16.38M |
| November 30, 2018 | 2.245M |
| August 31, 2018 | 6.081M |
| May 31, 2018 | 11.75M |
| February 28, 2018 | 1.32M |
| November 30, 2017 | -9.812M |
| August 31, 2017 | 3.673M |
| May 31, 2017 | 5.008M |
| February 28, 2017 | -25.15M |
| November 30, 2016 | -27.45M |
| August 31, 2016 | -41.54M |
| May 31, 2016 | -43.60M |
| February 29, 2016 | -1.339M |
| November 30, 2015 | -6.195M |
| August 31, 2015 | -4.495M |
| May 31, 2015 | -3.268M |
| February 28, 2015 | -3.532M |
| November 30, 2014 | 5.838M |
| August 31, 2014 | 4.401M |
| May 31, 2014 | 3.505M |
| February 28, 2014 | 3.715M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Boston Scientific Corp. | 3.669B |
| Penumbra, Inc. | 160.59M |
| Abbott Laboratories | 5.405B |
| Alphatec Holdings, Inc. | -109.99M |
| AtriCure, Inc. | 10.55M |